Tag: PTSD

US-listed BioAdaptives, Inc. (OTCID: BDPT) has signed a definitive agreement to acquire Xycota Biosciences LLC, a privately held biotechnology company ...

The Australian psychedelic-assisted therapy provider has reported record quarterly revenue of $1.42 million, expanded its national clinic network and received ...

New Zealand medicinal cannabis company Rua Bioscience has signed a distribution agreement with PharmAla Biotech, following the country's first approvals ...

Emyria has begun treating its first patients at a new Sydney clinic, extending its Empax mental health services into New ...

As psilocybin and MDMA move deeper into psychiatric research and clinical practice, the conversation is shifting from therapeutic promise towards ...

Emyria (ASX: EMD) is preparing to open its first Sydney clinic in September, with the company saying key operational milestones ...

New Zealand has authorised two psychiatrists to prescribe pharmaceutical-grade MDMA as part of supervised treatment for adults with post-traumatic stress ...

Psychedelic medicine has spent the past decade developing clinical evidence almost exclusively in adults. Adolescents have largely remained outside the ...

Australian psychedelic biotechnology company Entropy Neurodynamics (ASX: ENP) has secured Human Research Ethics Committee (HREC) approval to begin what it ...

Red Light Holland subsidiary Filament Health will supply its naturally derived psilocybin drug candidate, PEX010, for a new clinical trial ...